Rocket Pharmaceuticals News

4: Statement of changes in beneficial ownership of securities-Officer Wilson Martin

Nov 25 16:07 ET

4: Statement of changes in beneficial ownership of securities-Officer Shah Gaurav

Nov 25 16:07 ET

4: Statement of changes in beneficial ownership of securities-Officer Patel Kinnari

Nov 25 16:07 ET

4: Statement of changes in beneficial ownership of securities-Officer Militello John

Nov 25 16:07 ET

144: Notice of proposed sale of securities pursuant to Rule 144

Nov 21 16:30 ET

144: Notice of proposed sale of securities pursuant to Rule 144

Nov 21 16:10 ET

144: Notice of proposed sale of securities pursuant to Rule 144

Nov 21 16:00 ET

144: Notice of proposed sale of securities pursuant to Rule 144

Nov 21 15:30 ET

8-K: Current report

Nov 18 16:21 ET

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Wellington Management Group LLP(12.36%),Wellington Group Holdings LLP(12.36%), etc.

Nov 8 10:55 ET

10-Q: Q3 2024 Earnings Report

Nov 7 16:54 ET

8-K: Rocket Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Progress

Nov 7 16:29 ET

4: Statement of changes in beneficial ownership of securities-Officer Militello John

Nov 4 16:11 ET

4: Statement of changes in beneficial ownership of securities-Officer White Mark Andrew

Nov 4 16:10 ET

144: Notice of proposed sale of securities pursuant to Rule 144

Oct 31 15:35 ET

144: Notice of proposed sale of securities pursuant to Rule 144

Oct 31 15:26 ET

4: Statement of changes in beneficial ownership of securities-Director Bjork Elisabeth

Oct 29 17:10 ET

4: Statement of changes in beneficial ownership of securities-Director Makker Gotham

Oct 29 16:59 ET

8-K: Current report

Sep 11 16:13 ET

4: Statement of changes in beneficial ownership of securities-Director Dolsten Mikael

Sep 11 16:11 ET